Zim Laboratories Ltd
NSE:ZIMLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zim Laboratories Ltd
NSE:ZIMLAB
|
IN |
|
GSD Holding AS
IST:GSDHO.E
|
TR |
|
I
|
Immofinanz AG
VSE:IIA
|
AT |
|
G
|
Great Microwave Technology Co Ltd
SSE:688270
|
CN |
|
Dianguang Explosion-proof Technology Co Ltd
SZSE:002730
|
CN |
|
H
|
HUHUTECH International Group Inc
NASDAQ:HUHU
|
CN |
|
Cloetta AB
STO:CLA B
|
SE |
|
Pediatrix Medical Group Inc
BMV:MD
|
US |
|
Microtek International Inc
TWSE:2305
|
TW |
|
Vivoryon Therapeutics NV
AEX:VVY
|
DE |
|
Yang Ming Marine Transport Corp
TWSE:2609
|
TW |
|
H
|
Haoxin Holdings Ltd
NASDAQ:HXHX
|
CN |
|
Is Gayrimenkul Yatirim Ortakligi AS
IST:ISGYO.E
|
TR |
|
Compass Group PLC
LSE:CPG
|
UK |
|
Tirupati Tyres Ltd
BSE:539040
|
IN |
|
IGB Eletronica SA
BOVESPA:IGBR3
|
BR |
|
A
|
APR Co Ltd
KRX:278470
|
KR |
Bankruptcy Probability
Zim Laboratories Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Zim Laboratories Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Zim Laboratories Ltd
NSE:ZIMLAB
|
3.3B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
860.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
114.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Zim Laboratories Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Zim Laboratories Ltd has total debt of 467.2m INR. This includes both short-term (0 INR) and long-term (467.2m INR) debt.
You can find a full breakdown on its Balance Sheet.
